The following is a summary of “Time-dependent recovery of renal impairment in patients with newly diagnosed multiple myeloma, ...

That RA patients are at special risk for renal impairment and CKD isn't new. But how the progressive decline in kidney ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

In analyses that were adjusted for potential confounders, rates of major bleeding did not differ significantly between enoxaparin and UFH recipients, regardless of the degree of renal impairment.

Researchers assessed whether early albumin use among patients with septic shock and kidney impairment upon hospital admission reduced in-hospital mortality or the need for renal replacement ...

Rates of both MCI and composite of MCI or probable dementia lower with intensive treatment in extended follow-up study ...

Novo Nordisk has announced the results from Phase IIIa trial PIONEER 5, which investigated its oral semaglutide in adults with ...